The earnings call presented a positive outlook for Universal Health Services with strong revenue growth and effective expense management across both acute care and behavioral health segments. However, challenges such as decreased cash flow and uncertainties surrounding Medicaid supplemental payments posed concerns.

Company Guidance

During the UHS 2025 Q1 conference call, Steve Filton highlighted key metrics and guidance for the fiscal year. The company reported a net income attributable to UHS per diluted share of $4.80, with an adjusted figure of $4.84. Acute care hospital segment saw a 2.4% increase in adjusted admissions and a 5.0% rise in same-facility net revenues, excluding insurance subsidiary impacts. Operating expenses were well-managed, rising 2.6% on a same-facility basis. The EBITDA increased by 21% after excluding Medicaid supplemental payments. Behavioral health hospitals experienced a 5.5% increase in same-facility net revenues, driven by a 5.8% increase in revenue per adjusted day, despite relatively flat adjusted patient days. Cash generated from operating activities fell to $360 million, influenced by delays in Medicaid supplemental payments. UHS spent $239 million on capital expenditures and repurchased 1 million shares for $181 million. As of March 31, 2025, UHS had $1.02 billion of available borrowing capacity on its $1.3 billion revolving credit facility. The company reiterated its full-year earnings guidance, citing confidence in their underlying business performance despite external uncertainties.

Increase in Acute Care Hospital Metrics

Adjusted admissions to acute care hospitals increased by 2.4% and same facility net revenues increased by 5.0% in the first quarter of 2025 compared to the previous year.

Behavioral Health Revenue Growth

Same-facility net revenues at behavioral health hospitals increased by 5.5% due to a 5.8% increase in revenue per adjusted day.

Strong Operating Expense Management

Operating expenses on a same facility basis increased by only 2.6%, contributing to a 21% increase in EBITDA after excluding Medicaid supplemental payments.

Positive EBITDA from New Hospital

West Henderson Hospital in Las Vegas, opened in late 2024, posted a modestly positive EBITDA in its first full quarter.

Significant Share Repurchase

The company repurchased 1 million shares at a cost of approximately $181 million in Q1 2025, continuing a long-term trend of share buybacks.

---

Universal Health (DE:UHS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DE:UHS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jul 28, 2025	2025 (Q2)	4.47 / -	3.852	―	―	―
Apr 28, 2025	2025 (Q1)	3.89 / 4.33	3.307	30.81% (+1.02)	―
Feb 26, 2025	2024 (Q4)	3.72 / 4.40	2.798	57.19% (+1.60)	―
Oct 24, 2024	2024 (Q3)	3.32 / 3.32	2.279	45.49% (+1.04)	―
Jul 24, 2024	2024 (Q2)	2.95 / 3.85	2.261	70.36% (+1.59)	―
Apr 24, 2024	2024 (Q1)	2.81 / 3.31	2.092	58.12% (+1.22)	―
Feb 27, 2024	2023 (Q4)	2.58 / 2.80	2.699	3.64% (+0.10)	―
Oct 25, 2023	2023 (Q3)	2.12 / 2.28	2.27	0.39% (<+0.01)	―
Jul 25, 2023	2023 (Q2)	2.18 / 2.26	1.966	15.00% (+0.29)	―
Apr 25, 2023	2023 (Q1)	1.96 / 2.09	1.922	8.84% (+0.17)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

DE:UHS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 28, 2025	€150.00	€147.00	-2.00%
Feb 26, 2025	€179.81	€175.81	-2.22%
Oct 24, 2024	€215.56	€192.60	-10.65%
Jul 24, 2024	€169.51	€174.49	+2.94%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---